1848 related articles for article (PubMed ID: 16174856)
21. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
22. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
[TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
[TBL] [Abstract][Full Text] [Related]
25. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
[TBL] [Abstract][Full Text] [Related]
27. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
28. How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach.
Rino Y; Imada T; Kabara T; Takahashi M; Shiozawa M; Ohshima T; Hasuo K; Inaba M; Yoneyama K; Yoshikawa T; Yukawa H; Kawamoto M; Tokunaga M; Takanashi Y
Hepatogastroenterology; 2003; 50(54):2267-9. PubMed ID: 14696514
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
30. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma.
de Jong D; Vyth-Dreese F; Dellemijn T; Verra N; Ruskoné-Fourmestraux A; Lavergne-Slove A; Hart G; Boot H
J Pathol; 2001 Mar; 193(3):318-24. PubMed ID: 11241410
[TBL] [Abstract][Full Text] [Related]
31. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
32. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
[TBL] [Abstract][Full Text] [Related]
33. [MALT-type low-grade B-cell lymphomas of the stomach and Helicobacter pylori].
Binek J; Morant R; Weber A; Schmid U; Hammer B
Schweiz Med Wochenschr; 1996 May; 126(19):841-4. PubMed ID: 8693310
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
35. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
[TBL] [Abstract][Full Text] [Related]
37. [Gastric MALT lymphoma, clinical features].
Udvardy M
Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
[TBL] [Abstract][Full Text] [Related]
39. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
[TBL] [Abstract][Full Text] [Related]
40. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.
Enno A; O'Rourke J; Braye S; Howlett R; Lee A
Am J Pathol; 1998 Jun; 152(6):1625-32. PubMed ID: 9626066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
